Current and forecasted 10-year prevalence and incidence of inflammatory bowel disease in Hong Kong, Japan, and the United States

Figure 1 Crude prevalence and incidence of inflammatory bowel disease, Crohn’s disease, and ulcerative colitis in Hong Kong, Japan, and the United States. A: Crude prevalence in Hong Kong, Japan and the United States; B: Crude incidence in Hong Kong, Japan and the United States. Crude prevalence and incidence in Hong Kong were estimated using one diagnostic code definition. IBD: CD: Crohn’s disease; CDARS: Clinical data analysis and reporting system; Inflammatory bowel disease; JMDC: Japan Medical Data Center; Merative: The Merative™ MarketScan^® (“Merative” previously IBM MarketScan Commercial Claims and Encounters) database; UC: Ulcerative colitis.